These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1126587)

  • 1. Efficacy of inactivated Mycoplasma pneumoniae vaccine in man.
    Mogabgab WJ; Marchand S; Mills G; Beville R
    Dev Biol Stand; 1975; 28():597-608. PubMed ID: 1126587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective efficacy of killed Mycoplasma pneumoniae vaccine measured in large-scale studies in a military population.
    Mogabgab WJ
    Am Rev Respir Dis; 1973 Oct; 108(4):899-908. PubMed ID: 4582435
    [No Abstract]   [Full Text] [Related]  

  • 3. Protection by natural infection and vaccination against respiratory diseases caused by mycoplasmas.
    Whittlestone P
    Dev Biol Stand; 1975; 28():571-85. PubMed ID: 805075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Indicators of humoral immunity to M. pneumoniae in healthy children and in children with respiratory tract infections].
    Korzhenkova MP; Vorotyntseva NV; Lozovskaia LS; Mirishli AD; Rybakova II
    Vopr Okhr Materin Det; 1974 Nov; 19(11):16-21. PubMed ID: 4612965
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotaxis of human leukocytes: responsiveness to Mycoplasma pneumoniae.
    Martin RR; Warr G; Couch R; Knight V
    J Lab Clin Med; 1973 Apr; 81(4):520-9. PubMed ID: 4696185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isolation and use of a Mycoplasma hominis antigen in the laboratory diagnosis of respiratory diseases].
    Kruglikov VT; Mitchenko VP; Lisin VV; Zharkova LD
    Mikrobiol Zh (1978); 1987; 49(2):68-72. PubMed ID: 2471038
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of conventional and new generation tests for testing the humeral response to Mycoplasma pneumoniae antigens in natural infections in humans. II. Occurrence and level of mycoplasma antibodies in patients with respiratory tract infections].
    Rastawicki W
    Med Dosw Mikrobiol; 1995; 47(1-2):55-76. PubMed ID: 8523971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective efficacy of an inactivated Mycoplasma pneumoniae vaccine.
    Wenzel RP; Craven RB; Davies JA; Hendley JO; Hamory BH; Gwaltney JM
    J Infect Dis; 1977 Aug; 136 Suppl():S204-7. PubMed ID: 894086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of mycoplasma species in the respiratory tract (author's transl)].
    Fadda G
    Ann Sclavo; 1976; 18(2):249-59. PubMed ID: 1015869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adeno, parainfluenza, RS, and corona viruses and Mycoplasma pneumoniae as etiologic agents of acute respiratory tract infections.
    Borysiewicz J; Zgórniak-Nowosielska I; Oleksy J; Pastuszak J; Poteć Z
    Acta Microbiol Pol A; 1973; 5(3):102-6. PubMed ID: 4358712
    [No Abstract]   [Full Text] [Related]  

  • 11. Protective efficacy of Mycoplasma pneumoniae polysaccharides.
    Brunner H
    Isr J Med Sci; 1981 Jul; 17(7):678-81. PubMed ID: 6793538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Field trial of an inactivated Mycoplasma pneumoniae vaccine. I. Vaccine efficacy.
    Wenzel RP; Craven RB; Davies JA; Hendley JO; Hamory BH; Gwaltney JM
    J Infect Dis; 1976 Dec; 134(6):571-6. PubMed ID: 794422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of field studies using Stellamune mycoplasma vaccine in Luxembourg].
    Schoos J
    Bull Soc Sci Med Grand Duche Luxemb; 1998; 135(1):43-50. PubMed ID: 9868832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Report of a workshop: disease accentuation after immunization with inactivated microbial vaccines.
    Craighead JE
    J Infect Dis; 1975 Jun; 131(6):749-54. PubMed ID: 1169271
    [No Abstract]   [Full Text] [Related]  

  • 15. Further studies on the immunization of chickens with temperature-sensitive Mycoplasma gallisepticum mutant.
    Lam KM; Lin WQ
    Avian Dis; 1984; 28(1):131-8. PubMed ID: 6326734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Complement fixation reaction for Mycoplasma pneumoniae in the serologic diagnosis of respiratory diseases].
    Martelli A
    G Batteriol Virol Immunol Microbiol; 1972 Jan; 65(1):43-9. PubMed ID: 4364789
    [No Abstract]   [Full Text] [Related]  

  • 17. [Studies on the laboratory diagnostic use of a new complement binding Mycoplasma pneumoniae antigen].
    Stelzner A; Urbach H; Winter J
    Z Gesamte Hyg; 1973 Aug; 19(8):602-6. PubMed ID: 4778219
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of a vaccine against Mycoplasma gallisepticum in commercial broilers.
    Rodriguez R; Kleven SH
    Avian Dis; 1980; 24(4):879-89. PubMed ID: 7271643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of titer, preservation method, and storage of Mycoplasma gallisepticum F strain and the immune response in chickens.
    Lin MY; Kleven SH
    Avian Dis; 1984; 28(1):273-7. PubMed ID: 6721801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of Mycoplasma gallisepticum vaccines in young chickens.
    Abd-el-Motelib TY; Kleven SH
    Avian Dis; 1993; 37(4):981-7. PubMed ID: 8141758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.